Literature DB >> 29107326

Adult hippocampal neurogenesis in neuropathic pain and alkyl glycerol ethers treatment.

Anna A Tyrtyshnaia1, Igor V Manzhulo2, Ruslan M Sultanov3, Ekaterina V Ermolenko4.   

Abstract

Neuropathic pain manifested by a number of sensory symptoms is often accompanied by disorders of higher nervous activity, such as memory impairment, depression, anxiety, anhedonia, etc. This emphasizes the involvement of supraspinal structures including the hippocampus in neuropathic pain pathogenesis. In the present study, we focused on the impact of chronic neuropathic pain on hippocampal neurogenesis and microglial state. In addition, we test the effect of alkyl glycerol ethers on hippocampal neuronal and microglial plasticity as well as behavioral parameters. Neuropathic pain was induced using the model of sciatic nerve chronic constriction injury. We found an impairment of working memory and locomotor activity in animals with neuropathic pain, which was prevented by alkyl glycerol ethers treatment. Sciatic nerve ligation in mice contributed to the decrease in hippocampal neurogenesis intensity. Alkyl glycerol ethers administration significantly reduced this effect. Neuropathic pain-associated neurogenesis reduction was accompanied by an increased percentage of Iba1-labeled area in the CA1 hippocampal region on the 14th and 28th days after surgery. In addition, we observed a decrease in hippocampal pro-inflammatory microglia marker CD86 immunostaining on day 28 after surgery in alkyl glycerol ethers-treated mice with sciatic nerve ligation. These results are consistent with data on pro- and anti-inflammatory cytokines expression in the hippocampus. Alkyl glycerol ethers administration increased IL-10 and decreased IL-1β hippocampal expression in animals with neuropathic pain. Taken together, these data suggest that neuropathic pain-behavior in rodents is accompanied by changes in microglia polarization, thereby contributing to neurogenesis impairment and cognitive disturbances. Alkyl glycerol ethers prevented M1 microglial activation, contributing to the maintenance of normal neurogenesis levels within the hippocampus and normalizing working memory.
Copyright © 2017 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Alkyl glycerol ethers; Chimyl alcohol; Cytokines; Microglia; Neurogenesis; Neuropathic pain

Mesh:

Substances:

Year:  2017        PMID: 29107326     DOI: 10.1016/j.acthis.2017.10.007

Source DB:  PubMed          Journal:  Acta Histochem        ISSN: 0065-1281            Impact factor:   2.479


  5 in total

1.  Neuropathic Pain Causes Memory Deficits and Dendrite Tree Morphology Changes in Mouse Hippocampus.

Authors:  Anna Tyrtyshnaia; Igor Manzhulo
Journal:  J Pain Res       Date:  2020-02-11       Impact factor: 3.133

2.  Release of interleukin-10 and neurotrophic factors in the choroid plexus: possible inductors of neurogenesis following copolymer-1 immunization after cerebral ischemia.

Authors:  Yolanda Cruz; Edna E García; Jessica V Gálvez; Stella V Arias-Santiago; Horacio G Carvajal; Raúl Silva-García; Herlinda Bonilla-Jaime; Julio Rojas-Castañeda; Antonio Ibarra
Journal:  Neural Regen Res       Date:  2018-10       Impact factor: 5.135

3.  Neuroinflammation and adult hippocampal neurogenesis in neuropathic pain and alkyl glycerol ethers treatment in aged mice.

Authors:  Anna Tyrtyshnaia; Igor Manzhulo; Yulia Kipryushina; Ekaterina Ermolenko
Journal:  Int J Mol Med       Date:  2019-03-21       Impact factor: 4.101

4.  1-O-Alkylglycerol Ethers from the Marine Sponge Guitarra abbotti and Their Cytotoxic Activity.

Authors:  Sergey A Dyshlovoy; Sergey N Fedorov; Vasily I Svetashev; Tatiana N Makarieva; Anatoliy I Kalinovsky; Olga P Moiseenko; Vladimir B Krasokhin; Larisa K Shubina; Alla G Guzii; Gunhild von Amsberg; Valentin A Stonik
Journal:  Mar Drugs       Date:  2022-06-22       Impact factor: 6.085

5.  Trigeminal neuralgia causes neurodegeneration in rats associated with upregulation of the CD95/CD95L pathway.

Authors:  Lu Wang; Menghong Long; Maohua Wang; Shuangchun Peng; Guangxiang Chen; Jun Zhou; Cehua Ou
Journal:  Mol Pain       Date:  2020 Jan-Dec       Impact factor: 3.395

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.